Evolution Equity Partners, a renowned investment firm with a focus on cybersecurity, has announced the successful closure of its Evolution Technology Fund III, LP on April 16, 2024. The fund garnered a total capital commitment of $1.1 billion, oversubscribed by new and returning limited partners including top institutions, sovereign investors, insurance companies, endowments, foundations, funds of funds, family offices, and high-net-worth individuals. This major cybersecurity-focused fund involves a significant investment from British Patient Capital, a subsidiary of the British Business Bank and the UK’s leading domestic investor in scaling companies. Evolution Equity Partners, founded by technologists and investors Richard Seewald and Dennis Smith, plans to allocate the dedicated capital in investment opportunities ranging from $20 to $150 million across the cybersecurity sector. The firm seeks to create a diversified portfolio in key cybersecurity ecosystems in the US, UK, EU, and Israel. It has already significantly invested in numerous UK and EU-based companies such as AVG Technologies, Quantexa, Panaseer, DF Labs, Logpoint, CounterCraft, and more, among the 60 backed portfolio enterprises. Richard Seewald praises the strong entrepreneurial talent in cybersecurity in the European region and assures the firm’s unparalleled experience in Europe. Similarly, Christine Hockley of British Patient Capital commends Evolution Equity Partners’ cybersecurity specialization and its investment credentials for supporting the UK’s top tech firms. The firm operates with 30 specialized professionals across New York, Palo Alto, London, and Zurich and is driven by its Cybersecurity Centers of Excellence for Growth to efficiently drive startups from idea to IPO with a definitive operational manual.

Private Equity, Cybersecurity, Financial Services,United Kingdom, European Union, United States, Israel